FeesSafety
Pluang+

Saudi attacks keep crude oil prices high despite steady Middle East exports

Technical Signals
23 Oct 2026
FXEmpire
View Source
Bullish
Saudi attacks keep crude oil prices high despite steady Middle East exports

Crude oil prices are rising due to security concerns from recent attacks on Saudi oil infrastructure, even though Middle East exports remain near 17 million barrels per day. Traders are paying a premium for the safety of these barrels rather than reacting to an actual shortage. The market is closely watching potential supply relief from Russia lifting its diesel export ban and possible peace talks involving Russia and Ukraine, but these remain future risks rather than current factors. For now, the uptrend in crude prices is supported by ongoing geopolitical tensions and strong technical signals in futures trading.

Crude oil outlook as of Oct 23, 2026 17:21 WIB shows steady market activity. For readers following the energy sector, here is Pluang's market snapshot: out of 79 priced Energy-sector US stocks, 51 rose and 19 fell today. Notable movers include EQNR at USD 47.15 with a 1-day change of +1.57%, Solaris Energy Infrastructure (SEI) at USD 59.51 up +1.54%, and Denison Mines (DNN) at USD 2.19 up +1.39%. The most notable figure is the strong buy interest in SEI with 72% of Pluang order activity on the buy side.

More News

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Global zinc supply is expected to fall short by 88,000 tonnes in 2026 amid declining mine production, while tin demand is projected to outpace supply growth through 2035. This has renewed exploration in historic polymetallic mining districts in the U...

Market News
Bullish
19 minutes ago
Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...

Market News
Bullish
1 hour ago
Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...

Company Fundamentals
Bullish
1 hour ago
Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...

Company Fundamentals
Bullish
1 hour ago
eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...

Others
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App